An FDA committee voted unanimously last month to approve a new clinical endpoint, minimal residual disease, when evaluating proposed drugs to treat multipl
The preclinical phase of chronic lymphocytic leukemia may be exist longer than previously thought, suggests a sequencing analysis of blood samples obtained up to 22 years prior to diagnosis.